Related Experiment Video
Updated: Feb 5, 2026

Quantitative Analysis of Alternative Pre-mRNA Splicing in Mouse Brain Sections Using RNA In Situ Hybridization Assay
Published on: August 26, 2018
Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis
Carmen Berasain1,2,1,2, María Elizalde1,2,1,2, Raquel Urtasun1,2,1,2
1Division of Hepatology & Gene Therapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, CIMA, Avda, Pio XII, n55, 31008 Pamplona, Spain.
Abstract:
Hepatocellular carcinoma (HCC) is a molecularly complex tumor that is resistant to standard and targeted therapies, and thus a deadly disease. In this context, the identification of key alterations driving HCC development is therefore essential. The implementation of next-generation sequencing techniques has underscored earlier realizations of the marked dysregulation of pre-mRNA splicing in HCC. Impairments in alternative splicing may lead to the expression of protumorigenic protein isoforms and to the generation of unstable mRNA species. Mechanistically, mutations in key nucleotides are responsible for many of these alterations in different types of tumors. However, changes in the expression of factors involved in the regulation of the splicing machinery are also important determinants in the derangement of pre-mRNA splicing. Here we discuss recent reports on the alteration of splicing factors in HCC, the pathological significance of these changes, and the identification of cell signaling pathways leading to the missplicing of genes in hepatocarcinogenesis.
Insights
Altered pre-mRNA splicing, driven by changes in splicing factors, significantly contributes to hepatocellular carcinoma (HCC) development. Understanding these splicing dysregulations is crucial for developing new HCC therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a deadly cancer resistant to current treatments.
- Pre-mRNA splicing dysregulation is increasingly recognized as a key factor in HCC development.
- Alternative splicing can produce tumor-promoting protein isoforms and unstable mRNA.
Purpose of the Study:
- To review recent findings on altered splicing factors in HCC.
- To discuss the pathological significance of these splicing alterations.
- To identify signaling pathways involved in HCC-related gene missplicing.
Main Methods:
- Review of recent scientific literature on splicing factors in HCC.
- Analysis of next-generation sequencing data implicating splicing dysregulation.
- Discussion of molecular mechanisms and signaling pathways.
Main Results:
- Significant alterations in splicing factor expression are observed in HCC.
- These changes contribute to the expression of protumorigenic isoforms.
- Specific cell signaling pathways are linked to aberrant splicing in hepatocarcinogenesis.
Conclusions:
- Splicing factor alterations are critical drivers of HCC.
- Targeting splicing machinery presents a potential therapeutic strategy for HCC.
- Further research into splicing factor roles can illuminate HCC pathogenesis.
Related Concept Videos
Pre-mRNA Processing: RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability

